Biotech · Private company
MediBeacon
Track this companyFree. Adds MediBeacon to your Dealase workspace and tells you when its record changes.
Clinical trials94 recruiting or active
Pipeline programs22From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline22
- MB-102Phase 3 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MB-102Phase 3 · Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR)Phase 3 · Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR)Phase 3 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- IohexolPhase 2 · Acute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
- MB-102-- single dose of 130 mgPhase 2 · Acute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
- MB-102-- single dose of 4 µmol/kgPhase 2 · Acute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
- MB-102-- two doses of 130 mg 24 hours apartPhase 2 · Acute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
- MB-102-single dose of 130 mg or 2 doses of 130 mg 12 hours apartPhase 2 · Acute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
- QuantumLeapPhase 2 · Acute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
- Fluorescein sodium and commercially available optical angiography imaging systemPhase 1 · RetinopathyClinicalTrials.gov · fetched Nov 12, 2026
- Fluorescein sodium and Zeiss FF450 fundus cameraPhase 1 · RetinopathyClinicalTrials.gov · fetched Nov 12, 2026
- KARL STORZ POWER LED BLUE SystemPhase 1 · Ureter InjuryClinicalTrials.gov · fetched Nov 12, 2026
- Lactulose/Rhamnose solutionPhase 1 · Crohn DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- LumitracePhase 1 · Ureter InjuryClinicalTrials.gov · fetched Nov 12, 2026
- MB-102Phase 1 · Crohn DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MB-102 and commercially available optical angiography imaging systemPhase 1 · RetinopathyClinicalTrials.gov · fetched Nov 12, 2026
- MB-102 and Zeiss FF450 fundus cameraPhase 1 · RetinopathyClinicalTrials.gov · fetched Nov 12, 2026
- Brilliance device sensorAcute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
- IohexolGlomerular Filtration RateClinicalTrials.gov · fetched Nov 12, 2026
- LumitraceGlomerular Filtration RateClinicalTrials.gov · fetched Nov 12, 2026
- MediBeacon Transdermal Glomerular Filtration Rate Measurement System (TGFR)Glomerular Filtration RateClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- Evaluation of Protein Loading on Measurement of Renal ReserveNA · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07335614 · fetched Nov 12, 2026
- MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart FailureNA · RECRUITING · started Aug 10, 2026ClinicalTrials.gov NCT07349797 · fetched Nov 12, 2026
- Evaluation of Lumitrace for Visualizing Ureters During Abdominopelvic SurgeriesPHASE1 · ACTIVE_NOT_RECRUITING · started Jan 30, 2026ClinicalTrials.gov NCT07080008 · fetched Nov 12, 2026
- Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein SodiumEARLY_PHASE1 · RECRUITING · started Nov 6, 2025ClinicalTrials.gov NCT04008121 · fetched Nov 12, 2026
- Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive RingPHASE3 · COMPLETED · started Mar 20, 2023ClinicalTrials.gov NCT05777174 · fetched Nov 12, 2026
- Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised SubjectsPHASE3 · COMPLETED · started Jun 14, 2022ClinicalTrials.gov NCT05425719 · fetched Nov 12, 2026
- Oral Administration of MB-102 Versus Dual Sugar Testing for Gut PermeabilityEARLY_PHASE1 · COMPLETED · started Oct 27, 2019ClinicalTrials.gov NCT03962998 · fetched Nov 12, 2026
- Tolerability and Background Fluorescence of the MediBeacon Transdermal GFR Measurement SystemNA · COMPLETED · started Sep 16, 2019ClinicalTrials.gov NCT03810833 · fetched Nov 12, 2026
- Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color TypesPHASE2 · COMPLETED · started May 11, 2016ClinicalTrials.gov NCT02772276 · fetched Nov 12, 2026